Halozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, announced that Genentech, a member of the Roche...
Read moreThe U.S. FDA gave Janssen Biotech, a Johnson & Johnson company, and their research partner, Copenhagen, Denmark-based Genmab A/S, an...
Read moreTakeda Pharmaceutical Company Limited announced that the EC extended the current marketing authorization of ADCETRIS (brentuximab vedotin) to include treatment...
Read moreBristol-Myers Squibb Co. announced that the EC has approved Sprycel in combination with chemotherapy for the treatment of pediatric patients...
Read moreAstraZeneca and its global biologics research and development arm, MedImmune, announced that the US FDA has granted Breakthrough Therapy Designation...
Read moreNeovasc Inc., a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of...
Read moreCStone Pharmaceuticals announced that the National Medical Products Administration recently approved the clinical trial application (CTA) to start a Phase...
Read moreAmgen announced that the National Medical Products Administration (NMPA) has approved a new indication for Repatha as the first PCSK9...
Read moreSanofi has received approval from the US FDA for 0.5ml Fluzone Quadrivalent vaccine to treat influenza in children aged between...
Read moreClinical-stage company ImmusanT’s therapeutic vaccine candidate Nexvax2 has been granted fast track designation by the US FDA. ImmusanT uses its...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.